Rb and Prohibitin Target Distinct Regions of E2F1 for Repression and Respond to Different Upstream Signals

REFERENCES

• Adams, P. D., and J. Kaelin 1996. The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 208:79–93.
   PubMedGoogle Scholar
• Barnard, D., B. Diaz, D. Clawson, and J. Marshall 1998. Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene 17:1539–1547.
   PubMedGoogle Scholar
• Beijersbergen, R. L., and J. Bernards 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103–120.
   PubMed Web of Science ®Google Scholar
• Berger, K. H., and J. Yaffe 1998. Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces cerevisiae. Mol. Cell. Biol. 18:4043–4052.
   PubMedGoogle Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and J. Kouzarides 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and J. Phillips 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256–3265.
   PubMedGoogle Scholar
• Cartwright, P., H. Muller, C. Wagener, K. Holm, and J. Helin 1998. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17:611–623.
   PubMedGoogle Scholar
• Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. Nevins 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Coates, P. J., D. J. Jamieson, K. Smart, A. R. Prescott, and J. Hall 1997. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 7:607–610.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208:32–63.
   Google Scholar
• Cress, W. D., and J. Nevins 1994. Interacting domains of E2F1, DP1, and the adenovirus E4 protein. J. Virol. 68:4213–4219.
   PubMedGoogle Scholar
• Cress, W. D., and J. Nevins 1996. Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Curr. Top. Microbiol. Immunol. 208:63–78.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. Nevins 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245–7250.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., G. Leone, K. Ohtani, A. Miron, and J. Nevins 1995. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9:2873–2887.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Fabian, J. R., I. O. Daar, and J. Morrison 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170–7179.
   PubMed Web of Science ®Google Scholar
• Fanger, G. R., P. Gerwins, C. Widmann, M. B. Jarpe, and J. Johnson 1997. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7:67–74.
   PubMed Web of Science ®Google Scholar
• Field, S. J., F. Y. Tsai, F. Kuo, A. M. Zubiaga, W. J. Kaelin, D. M. Livingston, S. H. Orkin, and J. Greenberg 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549–561.
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., J. G. Wood, and J. Livingston 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 95:9190–9195.
   PubMedGoogle Scholar
• Hamel, P. A., R. M. Gill, R. A. Phillips, and J. Gallie 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431–3438.
   PubMed Web of Science ®Google Scholar
• Helin, K., J. A. Lees, M. Vidal, N. Dyson, H. Harlow, and J. Fattaey 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. Nevins 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349–352.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., K. Ohtani, and J. Nevins 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514–1525.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., and J. Schneider-Broussard 1998. Role of E2F in cell cycle control and cancer. Front. Biosci. 3:447–448.
   PubMedGoogle Scholar
• Kaelin, W. G., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, and J. Blanar 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351–364.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., H. Higashi, T. I. Suzuki, K. Segawa, S. K. Hanks, Y. Taya, S. Nishimura, and J. Okuyama 1995. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene 10:229–236.
   PubMed Web of Science ®Google Scholar
• Kowalik, T. F., J. DeGregori, G. Leone, L. Jakoi, and J. Nevins 1998. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9:113–118.
   PubMedGoogle Scholar
• Kowalik, T. F., J. DeGregori, J. K. Schwarz, and J. Nevins 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69:2491–2500.
   PubMedGoogle Scholar
• Krek, W., M. Ewen, S. Shirodkar, Z. Arany, W. J. Kaelin, and J. Livingston 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161–172.
   PubMed Web of Science ®Google Scholar
• Lam, E. W., M. S. Choi, J. van der Sman, S. A. Burbidge, and J. Klaus 1998. Modulation of E2F activity via signaling through surface IgM and CD40 receptors in WEHI-231 B lymphoma cells. J. Biol. Chem. 273:10051–10057.
   PubMed Web of Science ®Google Scholar
• Lam, E. W., and J. Watson 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705–2713.
   PubMed Web of Science ®Google Scholar
• La Thangue, N. B. 1994. Dp and E2F proteins: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Curr. Opin. Cell. Biol. 6:443–450.
   PubMed Web of Science ®Google Scholar
• La Thangue, N. B. 1996. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24:54–59.
   PubMed Web of Science ®Google Scholar
• Lee, C. W., T. S. Sorensen, N. Shikama, and J. La Thangue 1998. Functional interplay between p53 and E2F through co-activator p300. Oncogene 16:2695–2710.
   PubMedGoogle Scholar
• Lundberg, A. S., and J. Weinberg 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761.
   PubMed Web of Science ®Google Scholar
• Luo, R. X., A. A. Postigo, and J. Dean 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463–473.
   PubMed Web of Science ®Google Scholar
• Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and J. Harel-Bellan 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605.
   PubMed Web of Science ®Google Scholar
• McClung, J. K., E. R. Jupe, X.-T. Liu, and J. Dell’Orco 1995. Prohibitin: potential role in senescence, development and tumor suppression. Exp. Gerontol. 30:99–124.
   PubMed Web of Science ®Google Scholar
• Morooka, T., and J. Nishida 1998. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273:24285–24288.
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., D. R. Kaplan, J. A. Escobedo, U. R. Rapp, T. M. Roberts, and J. Williams 1989. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell 58:649–657.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585–593.
   PubMedGoogle Scholar
• Nuell, M. J., D. A. Stewart, L. Walker, V. Friedman, C. M. Wood, G. A. Owens, J. R. Smith, E. L. Schneider, O. R. Dell, C. K. Lumpkin et al.. 1991. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol. 11:1372–1381.
   PubMed Web of Science ®Google Scholar
• O’Connor, D. J., E. W. Lam, S. Griffin, S. Zhong, L. C. Leighton, S. A. Burbidge, and J. Lu 1995. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14:6184–6192.
   PubMedGoogle Scholar
• Qin, X. Q., D. M. Livingston, M. Ewen, W. R. Sellers, Z. Arany, W. G. Kaelin Jr.. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15:742–755.
   PubMedGoogle Scholar
• Qin, X. Q., D. M. Livingston, W. J. Kaelin, and J. Adams 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918–10922.
   PubMed Web of Science ®Google Scholar
• Rasmussen, R. K., H. Ji, J. S. Eddes, R. L. Moritz, G. E. Reid, R. J. Simpson, and J. Dorow 1998. Two-dimensional electrophoretic analysis of mixed lineage kinase 2 N-terminal domain binding proteins. Electrophoresis 19:809–817.
   PubMedGoogle Scholar
• Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, W. G. Kaelin Jr.. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95–106.
   PubMed Web of Science ®Google Scholar
• Shan, B., T. Durfee, and J. Lee 1996. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 93:679–684.
   PubMed Web of Science ®Google Scholar
• Singh, P., S. H. Wong, and J. Hong 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329–3338.
   PubMed Web of Science ®Google Scholar
• Slansky, J. E., and J. Farnham 1996. Introduction of the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208:1–30.
   PubMed Web of Science ®Google Scholar
• Sorensen, R. S., R. Girling, C.-W. Lee, J. Gannon, L. Bandara, and J. La Thangue 1996. Functional interaction between DP-1 and p53. Mol. Cell. Biol. 16:5888–5895.
   PubMedGoogle Scholar
• Steglich, G., W. Neupert, and J. Langer 1999. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol. Cell. Biol. 19:3435–3442.
   PubMed Web of Science ®Google Scholar
• Strom, D. K., J. L. Cleveland, S. Chellappan, J. Nip, and J. Hiebert 1998. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ. 9:59–69.
   PubMedGoogle Scholar
• Taya, Y. 1997. RB kinases and RB-binding proteins: new points of view. Trends Biochem. Sci. 22:14–17.
   PubMedGoogle Scholar
• Terashima, M., K. M. Kim, T. Adachi, P. J. Nielsen, M. Reth, G. Kohler, and J. Lamers 1994. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 13:3782–3792.
   PubMed Web of Science ®Google Scholar
• Tong, L., S. Pav, D. M. White, S. Rogers, K. M. Crane, C. L. Cywin, M. L. Brown, and J. Pargellis 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4:311–316.
   PubMedGoogle Scholar
• Tordai, A., R. A. Franklin, H. Patel, A. M. Gardner, G. L. Johnson, and J. Gelfand 1994. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes. J. Biol. Chem. 269:7538–7543.
   PubMedGoogle Scholar
• Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. Lees 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850–2855.
   PubMed Web of Science ®Google Scholar
• Trouche, D., A. Cook, and J. Kouzarides 1996. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24:4139–4145.
   PubMed Web of Science ®Google Scholar
• Trouche, D., and J. Kouzarides 1996. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc. Natl. Acad. Sci. USA 93:1439–1442.
   PubMedGoogle Scholar
• Wang, S., R. Ghosh, and J. Chellappan 1998. Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation. Mol. Cell. Biol. 18:7487–7498.
   PubMed Web of Science ®Google Scholar
• Wang, S., N. Nath, M. Adlam, and J. Chellappan 1999. Prohibitin, a potential tumor suppressor, interacts with Rb and regulates E2F function. Oncogene 18:3501–3510.
   PubMed Web of Science ®Google Scholar
• Wang, S., N. Nath, A. Minden, and J. Chellappan 1999. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 18:1559–1570.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and J. Dean 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., C. A. Prater, and J. Dean 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259–261.
   PubMed Web of Science ®Google Scholar
• Wu, X., and J. Levine 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602–3606.
   PubMed Web of Science ®Google Scholar
• Xiao, Z. X., J. Chen, A. J. Levine, N. Modjtahedi, J. Xing, W. R. Sellers, and J. Livingston 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694–698.
   PubMed Web of Science ®Google Scholar
• Xu, M., K. A. Sheppard, C. Y. Peng, A. S. Yee, and J. Piwnica 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14:8420–8431.
   PubMed Web of Science ®Google Scholar
• Young, P. R., M. M. McLaughlin, S. Kumar, S. Kassis et al.. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272:12116–12121.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and J. Chellappan 1995. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 10:2085–2093.
   PubMed Web of Science ®Google Scholar